← SynDRA
DANUSERTIB
SynDRA canonical compound SYN0009120 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | AURKB |
| Mechanism of action | Growth factor receptor inhibitor |
All known targets
- AURKA
- AURKB
- AURKC
- FGFR1
- NTRK1
- RET
- BCR
- SLK
Mechanisms of action (all sources)
- aurora kinase inhibitor
- Growth factor receptor inhibitor
- AURKB INHIBITOR
- Serine/threonine-protein kinase Aurora inhibitor
- AURKC INHIBITOR
- AURKA INHIBITOR
Cross-references
Synonyms
- PHA-739358
- DANUSERTIB (PHA-739358)
- PHA 739358
- Danusertib, PHA-739358
- (R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide
- 5-Amido-pyrrolopyrazole 9d
- Danusertib (PHA-739358)
- Danusertib [INN]
- PHA739358
- CHEMBL402548
- M3X659D0FY
- PHA-739358 (danusertib)
- MMV676600
- N-(5-((2R)-2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide
- N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
- UNII-M3X659D0FY
- (R)-N-(5-(2-Methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo-[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide
- N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide
- N-{5-[(2R)-2-methoxy-2-phenylethanoyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide
- DANUSERTIB [WHO-DD]
- PHA-739358,Danusertib
- MLS006011243
- Danusertib; PHA-739358
- SCHEMBL466509
- GTPL7937
- Danusertib - PHA-739358
- BDBM12985
- CHEBI:94490
- 2j50
- BCPP000266
- DTXSID301002864
- BCP01750
- EX-A1599
- ZINC6718723
- MFCD12024692
- NSC784415
- NSC800086
- AKOS015896691
Look up DANUSERTIB in the interactive SynDRA portal →